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The Effects of Heat-Killed Echinostomatid Parasites on Mice Treated with Dextran Sodium
Sulfate (DSS)
Natalie Gooder
Abstract
Objective: Autoimmune diseases are chronic, incurable, and affect approximately 50 million
Americans. This is a strong need for better ways to treat autoimmune diseases. Parasites and
parasite proteins have been observed to protect mice from symptoms of induced colitis in mice
treated with dextran sodium sulfate (DSS), a model for inflammatory bowel disease (IBD). I
hypothesize that non-living echinostomatid parasites, given during DSS treatment, can decrease
intestinal inflammation and weight loss, providing a possible novel treatment for IBD.
Methods: A range of DSS concentrations (0.5%-3%) were delivered to female C57BL/6 mice in
their drinking water in order to determine the concentration that induced colitis but not severe
morbidity; 1% DSS was determined to be optimal. Next, two groups of mice were administered
1% DSS in their drinking water for the first six days of the nine-day experiment, while two groups
received regular water throughout. The mice in one of the DSS treatment groups and one of the
water control groups were orally administered heat-killed metacercariae in PBS on the third day
of the experiment, while the remaining mice were administered just PBS as a control treatment.
Weight of the mice and intestinal distress were monitored, as was water and food consumption.
At the end of the experiment, colon lengths were measured and splenic cytokines (IL-4, IFN-γ, IL10, and IL-2) were assessed by ELISA.
Results: Mice with DSS induced colitis that received the parasite treatment demonstrated more
weight loss (p=0.01) and poorer intestinal distress (p=0.02) on the ninth day when compared to
mice with DSS induced colitis that did not receive parasite treatment. The spleens from mice
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receiving DSS and parasite treatment showed lower levels of regulatory cytokine IL-2 than mice
receiving DSS but not parasite treatment (p=0.013). Additionally, mice treated with DSS
consumed less food on average than untreated mice (p<0.0001).
Conclusion: In contrast to my hypothesis, I found that feeding mice heat-killed echinostomatid
parasites during DSS treatment did not improve symptoms of colitis. Future studies could be
performed to determine if non living parasites can counteract symptoms of colitis, a possible
novel treatment for patients with IBD.
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1.

Introduction

1.1.

IBD and the Hygiene Hypothesis
The 20th century brought forth better sanitation, high quality water, vaccines, and

antibiotics within industrialized countries, leading to a decline in microbial and parasitic
infections (1,2,3). However, the 20th century also ushered in asthma, allergies, and a host of
autoimmune diseases that had been uncommon previously and remain so in less developed
countries (2-4). While genetics and viruses are likely to be involved in autoimmunity (for
example, if one identical twin has type 1 diabetes, the other twin has a 30% greater chance of
developing the disease (5)), the increase in these diseases within the last 50 years has been so
rapid that environmental changes are strongly suggested (5,6).
Epidemiologic data and animal experimentation suggest that the elimination of
helminth parasites contributes to the increasing prevalence of some immune mediated diseases,
including inflammatory bowel disease (IBD), type 1 diabetes (T1D), multiple sclerosis (MS),
rheumatoid arthritis (RA), asthma, and food allergies (2). IBD, including Crohn’s disease (CD),
which affects both the distal ileum and colon, and ulcerative colitis (UC), which affects the colon
only, is characterized by chronic intestinal inflammation and epithelial damage (1,2,5-9) and
usually begins during the second or third decade of life (8). IBD has been steadily increasing
since the mid-20th century, making it a significant health problem within developed countries
(1,2). It is estimated that over 2 million people in the USA or Europe have IBD (2,8), which is a 34-fold increase since 1950 (5). In 2014, the CDC reported an incidence rate of anywhere
between 3 and 20 cases of IBD per 100,000 individuals in the US (7).
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The etiology of IBD is not certain and can vary between patients with UC or CD. Because
the colon and terminal ileum contain most of the intestinal flora (2), one hypothesis is that IBD
can result from an uncontrolled immune response to the normal gut flora (1). Another
hypothesis is that IBD is caused by an increased production of autoantibodies towards goblet
cells (10). No known bacterial or viral infections have been linked to IBD, although genetics can
play a role in predisposing patients (1,2,6-9). Epidemiological studies show an inverse
relationship between the frequency of helminth worm infections and IBD (1). IBD is common in
industrialized countries where human helminth infections are relatively sparse. Likewise, IBD is
uncommon in less developed areas of the world where helminth infections are endemic, such as
tropical countries in Asia and Africa (Fig. 1) (8,9).
The rarity of IBD in tropical countries cannot be explained based on genetics alone, as
descendants of immigrants from other countries acquire the higher risk of IBD of the adopted
developed country (9). The hygiene hypothesis was initially proposed by Strachan for hay fever
and is now proposed for several immunological disorders, including allergic diseases and
asthma, cardiovascular diseases, T1D, MS, and IBD (1). Hay fever was less frequent in children
from larger families where exchange of infections was common, as well as children exposed to a
farming environment, or certain food born or oral-fecal infections (3). This led to the hypothesis
that the stimulation of the immune system by microbes or microbial products protects from the
development of inflammatory diseases, therefore a reduced exposure to infectious agents may
explain the rise in allergic and autoimmune diseases (3)
The hygiene hypothesis for IBD is supported by geographical distribution, as IBD is seen
more frequently among patients with a higher socioeconomic status, associated with better
sanitation, high-quality water, and better medical standards (1). In contrast, countries with
higher infant mortality rates have lower reported incidence of IBD (1).
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Fig. 1. Global data shows an inverse correlation of IBD and helminth infections. (A) 2012 prevalence
of Schistosoma trematode infections (https://www.infectionlandscapes.org). (B) 2015 incidence of
IBD (https://oncofertility.northwestern.edu).

1.2.

The Immune System
The immune system is made up of both nonspecific (innate) and specific (adaptive)

branches. The innate immune system includes phagocytes, such as neutrophils and
macrophages, dendritic cells, and cytotoxic cells like natural killer (NK) cells, which work to
rapidly control a pathogenic invasion (1,9). Adaptive immune cells, known as B and T
lymphocytes, are antigen specific (1). Antigens are taken up by antigen presenting cells (APCs)
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expressing MHC classes, such as dendritic cells and macrophages (1). APC’s present fragments
of the antigen to T cells, and function to release cytokines, or signaling proteins, and direct naïve
T cells to differentiate into T helper cells (TH1, TH2) or regulatory T cells (TREG) (1,4,9). B cells can
recognize free antigens and can serve as APCs, leading to optimal antigen-specific CD4+ T cell
expansion (1). They can also differentiate into plasma cells that produce antibodies (IgG, IgA,
IgM, IgE, IgD), which fight infection by tagging pathogens for destruction by phagocytes and
other effector cells (4,11). Adaptive immune responses are initially slow but improve on
repeated exposure to a given antigen by the formation of B and T memory cells (1).
The balance between activating and inhibitory subsets of immune cells is important for
the immune system to work optimally (11,12). This is most clearly understood for T cells, in
which effector T cells and regulatory T cells have opposing roles in maintaining this balance
(11,12). CD4+ TH1 cells secrete proinflammatory cytokines IFN-γ and IL-12 (Fig. 2), which
enhance macrophage activity and promote the production of IgG during a normal immune
response (1,9,10,13). These cytokines are also associated with autoimmune diseases such IBD,
T1D, RA, and MS (1-3,5-8,11-20). TH1 cells additionally secrete IL-2, which is important for the
proliferation of T cells, and research suggests that IL-2 specifically induces TREG cells and is an
important regulator of autoimmunity (1,21). CD4+ TH2 cells secrete IL-4, IL-5, IL-9, and IL-13 (Fig.
2) which promote B cell production of IgE and signal the release of granules within basophils and
eosinophils (1,9,10,13). Basophils contain histamines within their granules and are associated
with allergies, whereas eosinophils are often associated with helminth infections (1,20).
Additionally, TH2 cells can secrete IL-10, a cytokine with well-known anti-inflammatory and
immunosuppressive properties (10). IL-10 blocks inflammatory cytokine production by T cells,
NK cells, and macrophages, and can also induce T cell anergy (a state of immune
unresponsiveness) in self-reactive T cells (10).
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TH1 and TH2 cells cross
regulate one another (9). IFN-γ
secreted by TH1 cells directly
suppresses IL-4 production and
inhibits the differentiation of
naïve T cells into TH2 cells,
whereas IL-4 and IL-10 inhibit the
secretion of IL-12 and IFN-γ,
Fig. 2. Overview of T cell subsets and cytokine production. TH1
specific cytokines IFN-γ and IL-12 cycle between immune cells
and induce inflammatory responses. TH2 specific cytokines IL-4,
IL-5, IL-9, and IL-13 are triggered by allergic or parasitic
infections and release granules in eosinophils or basophils. TH2
cells can also be a source of regulatory cytokine IL-10. TREG cells
function to regulate immune responses by producing IL-10 and
TGF-β, which block cytokine production of other T cells subsets.
Additionally, TH1 cells produce IL-2 which stimulates TREG cell
production. *Indicates cytokines analyzed in this study

blocking polarization into TH1 cells
(9). T cells isolated from the
colons of patients suffering from
Crohn’s disease produce large
amounts of IFN-γ and little IL-4 or

IL-10 (9). Shifting the paradigm of a TH1 cytokine-rich environment towards a TH2 polarized
environment was proposed as a mode of therapy for autoimmune diseases including IBD (21),
since chronic inflammation within the GI tract is TH1 mediated (2,5,6,8,9,15,16,22).
The murine gut also harbors large numbers of Foxp3 CD4+ TREG cells, which function to
restrain the host immune response to the normal intestinal flora (2). TREG cells release IL-10 and
TGF-β (Fig. 2) and regulate the immune system by inhibiting pro-inflammatory cytokine
production (2,4,11). B regulatory cells (BREG) are also a source of IL-10 and control intestinal
inflammation by decreasing IFN-γ levels (11,12). Furthermore, once stimulated BREG cells
continue to produce IL-10, leading to long term regulation of the immune system (11).
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1.3.

Helminth Parasites and IBD
Helminth parasites colonize more than one third of the world population and human

infections are common within developing countries (1). For chronic infection to occur, the
parasite must first avoid clearance by the host immune system by altering mucosal and systemic
immunity and inhibiting inflammatory responses (8). The exact mechanism for this is unknown
and can vary between different autoimmune diseases and different animal models. During the
acute phase of a parasitic infection, a TH2 response is initiated within the host (19), leading to IL4, IL-10, and IgE production and the release of granules within eosinophils (9,10). A shift from
TH1 to TH2 profiles in hosts was initially used to explain evidence that helminth parasites protect
from autoimmune disease but does not explain the rise in allergies within developed countries,
which are TH2 dependent (1-3,5,7,14).
Helminths can also protect from allergic reactions within a host, suggesting that
additional mechanisms of regulation must occur that are independent of TH2 cytokines (2). It is
suggested that during the chronic phase of infection, helminths produce several products with
immune modulatory properties including molecules that induce TREG cells and inhibit the
effector function of self-reactive T cells (2,19). However, other studies suggest that parasite
induced protection of IBD can inhibit TH1 proliferation without the need for IL-10 or TGF-β (2).
In one study it was demonstrated that helminth infections in IL-10 deficient mice still prevent
colitis (2). It has also been shown that regulatory dendritic cells and alternatively activated
macrophages (M2) inhibit T effector cell function in a manner independent of TREG cells, IL-10
and TGF-β (2). Also, because intestinal helminths must breach the mucosal barrier to reach the
immune system it has been suggested that direct interactions between intestinal helminths and
the gut epithelium may play a role in regulating symptoms of IBD (2).
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1.4.

Effect of Parasites on Colitis
The effects of helminth parasites on autoimmune diseases have been tested in multiple

studies within the last 20 years, confirming that parasites can protect from chronic inflammation
(1-5,7,9,12,13,15-20,23). IBD is characterized by intestinal inflammation and epithelial damage,
and includes symptoms of bloody diarrhea, pain, fatigue, and weight loss (6-9,14,16,20,22).
Chemical-induced colitis models, including trinitrobenzene sulfonic acid (TNBS), and dextran
sulfate sodium (DSS) are widely used in research studies and closely mimic the symptoms of
human IBD (9,16,20,22-24). DSS induces colitis in mice by forming nano-lipocomplexes with
medium-chain-length fatty acids in the colon (24). The DSS-induced colitis model has been
shown to induce changes in TH1/TH2 cytokine profiles, leading to an increase in proinflammatory cytokines (8,16,20).
Elliott et al. proposed the hypothesis that the loss of exposure to parasitic worms
increased the risk of IBD and illustrated a protective response of Schistosoma mansoni infection
on TNBS-induced colitis is mice (1). Schistosoma mansoni is a water-borne blood fluke that
infects human blood vessels near the intestinal tract, causing intestinal schistosomiasis (14,20).
Schistosomes undergo their intermediate life cycle by infecting snails, then adult larvae can
penetrate through the skin of humans (20). Clinical symptoms develop when schistosome eggs
migrate through intestinal tissue (20). Smith et al. demonstrated a protective response of S.
mansoni worms on DSS-induced colitis in BALB/c mice, showing that mice subcutaneously
infected with male cercariae and treated with 5% DSS 7-8 weeks post infection had significantly
reduced intestinal distress indicated by less weight loss, lower intestinal scores, and longer colon
lengths after dissection then uninfected mice (20). Infection of BALB/c mice with S. mansoni
was shown to protect mice from symptoms of colitis through the induction of M2 macrophages,
independent of TREG cells, IL-10, and TGF-β (2). Smith et al. further demonstrated that S.
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mansoni eggs do not induce protection from DSS-induced colitis in BALB/c mice by
subcutaneously infecting mice with both male and female cercariae and treating with DSS 4
weeks after egg laying had commenced (20). Mice developed more severe colitis when infected
with S. mansoni eggs then uninfected mice, suggesting that protection from colitis is only
achieved through the adult larvae cycle of S. mansoni (20).
In response to overwhelming evidence that helminth parasite infections protect from
induced colitis in mice, Summers and Weinstock et al. performed a series of clinical studies,
treating IBD patients with Trichuris suis eggs (1,2,8). Trichuris suis is an intestinal whipworm
commonly found in pigs (8,14.). T. suis does not require an intermediate host; its eggs are
passed in feces from infected animals and its juvenile larvae can directly penetrate the mucosa
of the intestines (14). While T. suis is not a human parasite, its juvenile worms can colonize a
human host for several weeks and are eliminated thereafter without any specific therapy (8). If
clinical symptoms occur in humans, they are mild and treatable (8,14). In these studies, 29
patients with long standing Crohn’s Disease, and 45 patients with Ulcerative Colitis were orally
infected with Trichuris suis eggs (1,2,8). After 24 weeks, 21 patients with CD were in remission,
and another two had improved symptoms (2,8). Additionally, about 50% of patients with UC
reported improved symptoms (1,8).
The use of living infectious parasites may not be necessary for treating patients with
autoimmune disease. It has been shown that excretory/secretory products of Fasciola hepatica
parasites, collected after culturing them in vitro, exert a potent immune-modulatory effect in
BALB/c and C57BL/6 mice by activated regulatory M2 macrophages, suppressing dendritic cell
maturation, and inhibiting TH1 cell differentiation (13,19). Another study delivered a single
recombinant parasite protein, galectin, isolated from the Toxascaris leonine nematode to
C57BL/6 mice prior to treatment with DSS (16). Galectins are highly conserved animal lectins
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with an affinity for β-galactose containing oligosaccharides (16,25), and have been shown to
affect different functions relevant to innate and adaptive immunity (16). Previous studies have
suggested that galectin-8 may play a suppressive role in IBD and RA. Mice injected with
galectin-8 (rTI-GAL) before treatment with DSS demonstrated less weight loss, lower intestinal
scores, longer colons after dissection, lower levels of IFN-γ and IL-4, and higher levels of IL-10
and TGF-β compared to mice not injected with rTI-GAL before DSS treatment (16).
In previous studies of parasites on mice models of colitis, the subcutaneous infection
with a parasite, or the injection of a parasite protein was delivered before treatment with DSS,
as a prevention method of DSS-induced colitis (Fig. 3) (9,16,20). It is currently unknown whether
administering parasites or parasite products during treatment with DSS can also decrease
symptoms of induced colitis in mice. Also, because a
parasite protein is enough to protect mice from DSSinduced colitis (16), we questioned whether feeding
mice non-living whole parasites could also decrease
symptoms of induced colitis. This study addresses
whether feeding C57BL/6 mice whole, heat-killed
parasites after several days of DSS treatment will
decrease symptoms of DSS-induced intestinal
damage, resulting in less weight loss, improved
intestinal health, and longer colon lengths after
Fig 3. Parasites or recombinant parasite
proteins (galectin) have been shown to protect
from DSS-induced colitis in mice when mice
are infected with cercariae or injected with
galectin prior to treatment with DSS.

dissection, and whether a decrease in symptoms is
accompanied by a shift in TH1 cytokines to TH2 and
TREG cytokines.
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1.5.

Rationale and Hypothesis
Echinostomatids are a family of intestinal parasites from the class Trematoda

(flatworms) and can cause disease in mammals and birds (1,14,26). Typically, the life cycle of
echinostomatids includes three different hosts: an invertebrate first intermediate host, typically
a mollusk, a second intermediate host carrying the encysted metacercarial stage, and a
vertebrate definitive host (26). Echinostome metacercariae can be obtained locally from
infected snails. Here, we test the effects of feeding heat-killed echinostome metacercariae to
C57BL/6 mice after three days of DSS treatment. We hypothesize that C57BL/6 mice treated
with DSS for 6 days and administered heat-killed metacercariae during DSS treatment will show
less weight loss, improved intestinal health, and longer colon lengths after dissection than mice
treated with DSS but not administered metacercariae. Furthermore, we hypothesize that a
decrease in symptoms can be linked to a decrease in inflammatory cytokines IFN-γ and IL-4,
and/or an increase in regulatory cytokines IL-10 and IL-2.

1.6

Summary
Research described in this thesis demonstrates that 3%, 2.25%, or 1.5% DSS dissolved in

drinking water for 6 days causes loose stools that are highly bloody and/or weight loss of over
25% of the initial body weight, whereas 1% DSS causes loose stools and weight loss of less than
25% of the initial body weight, and 0.5% DSS does not cause significant intestinal distress.
Furthermore, mice treated with 3%, 2.25%, 1.5%, or 1% DSS drink less water on average than
untreated mice. Mice treated with 1% DSS for 6 days and administered heat-killed echinostome
metacercariae during DSS treatment do not show less weight loss, improved intestinal health, or
longer colons after dissection when compared to mice treated with 1% DSS and administered
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PBS. Inversely, mice administered metacercariae during DSS treatment show more weight loss
and higher intestinal scores on the ninth day. However, mice administered PBS and treated with
1% DSS lose less weight than mice treated with 1% DSS in the initial trial, and mice administered
PBS and given regular water gain less weight than control mice in the initial trial. Analysis of
splenic cytokines show a decrease in regulatory cytokine IL-2 levels in mice treated with DSS and
administered metacercariae when compared to mice in all other groups. Furthermore, mice
treated with 1% DSS consume less food then untreated mice.
We conclude that heat-killed metacercariae fed orally to C57BL/6 mice after several
days of DSS treatment do not decrease symptoms of DSS-induced colitis but may exacerbate
symptoms. Because previous studies provided an ongoing parasite stimulus to protect from
immune mediated symptoms (1,2,9,13,16,18,20), we question whether delivering multiple
doses of metacercariae during DSS treatment could decrease symptoms of induced colitis. We
also question whether gavaging mice or administering PBS orally affects water consumption and
therefore weight loss. Further studies may be necessary to determine whether nonliving whole
parasites can be used as a form of treatment for models of IBD or other autoimmune diseases.
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2.

Methods

2.1.

DSS-induced model of colitis
It has been previously shown that mice models of colitis can be established in C57BL/6

mice by dissolving small amounts of dextran sodium sulfate (DSS) salt into drinking water
(16,20,23,24). An optimal DSS dosage is needed to test the effects of heat-killed parasite
treatment on mediating DSS-induced colitis to model the autoimmune disorder, inflammatory
bowel disease (IBD). Many factors affect DSS-induced colitis, including mouse age, gender,
strain, and environmental conditions of vivarium (23), therefore a range of DSS doses were
tested. An optimal dosage will result in the slow and steady onset of symptoms, and the mice
will remain healthy enough to last throughout the experimental period (23).
Since the effects of DSS can be variable, five mice were included per group. Three
groups were given different DSS (36-50,000 M. Wt., MP Biomedicals) concentrations dissolved in
drinking water with a fourth group used as a control. Initially, a range of 1.5%-3% DSS was
tested, then the experiment was repeated using 0.5%-1.5% DSS. Prior to each 9-day
experiment, mice were sedated using a mixture of 4% isoflurane gas with 1% oxygen and
identified with ear tags, then assigned to random groups (randomlists.com/team-generator).
On Day 0, the mice were weighed, and the groups adjusted so that each group had a similar
average weight (Tables 1 and 2). Mice in each group were divided into two cages to prevent
overcrowding. To minimize cage variance, each treatment group had one cage with two mice
and one cage with three mice. DSS treatment was given on days 0-5, and regular water on days
6-9.
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Table 1. Mice ID numbers and initial weight for
Experiment 1.
Amount of
DSS

Age on Day
0

Mice ID

Weight (g)

1.5% DSS

7 w, 1 d
7 w, 1 d
6 w, 6 d
6 w, 6 d
6 w, 6 d

913
915
919
933
921
Average=

16.92
15.87
17.64
15.76
18.17
16.87

2.25% DSS

7 w, 7 d
6 w, 6 d
7 w, 1 d
7 w, 1 d
6 w, 5 d

910
925
912
918
928
Average=

18.46
16.4
15.75
16.93
16.92
16.89

3% DSS

7 w, 1 d
7 w, 7 d
7 w, 1 d
6 w, 6 d
6 w, 6 d

917
911
916
923
924
Average=

17.17
18.58
15.5
17.76
17.42
17.29

0% DSS

6 w, 6 d
6 w, 4 d
6 w, 6 d
6w
6w

920
929
927
930
932
Average=

17.3
18.04
16.7
17.4
15
16.89

Table 2. Mice ID numbers and initial weight for
Experiment 2.

Amount
of DSS

Age on Day
0

Mice ID

Weight (g)

0.5% DSS

7 w, 3 d
7 w, 3 d
8w
8w
7 w, 3 d

32
29
14
17
34
Average=

17.69
17.62
17.85
17.44
17.48
17.62

1% DSS

7 w, 3 d
6 w, 6 d
8w
6 w, 6 d
6 w, 2 d

33
23
15
21
31
Average=

18.85
18.72
18.57
18.03
13.84
17.6

1.5% DSS

6 w, 6 d
6 w, 6 d
8w
6 w, 3 d
6 w, 5 d

22
25
13
47
36
Average=

18.12
18.14
18.25
16.86
16.78
17.63

0% DSS

6 w, 5 d
6 w, 6 d
6 w, 3 d
8w
8w

35
24
45
19
18
Average=

17.11
19.18
15.46
17.68
18.36
17.56

The control group was given regular water throughout the experiment. DSS solutions/water
were changed every two days with the remaining volume recorded and divided by the number
of mice per cage to determine average water consumption.
At approximately the same time each day, mice were individually weighed and placed in
an empty cage to allow for stool collection. Stool consistency was recorded, and two different
areas of the stool were smeared on a hema-screenTM card (Immunostics) to detect for fecal
blood. Hema-screen cards contain the compound guaiac (alpha-guaiaconic acid), which is
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oxidized by hemoglobin, resulting in a dark blue color within 30 seconds in the presence of
blood. For the initial experiment, stools were rated on a scale of 0-4 for stool consistency and
presence of fecal blood (0=Normal stool, -blood; 1=normal stool, +blood, or soft stool, -blood;
2=soft stool, +blood, or loose stool, -blood; 3=loose stool, + blood, or diarrhea, -blood;
4=diarrhea, +blood) (Table 3). For the second experiment, visible blood in stools was included
as a factor (4=loose bloody stool, +blood; 5=bloody diarrhea, +blood) (Table 4).
At the beginning of each experiment, a humane handling weight (75% of weight on Day
0) was calculated for all mice and if any mice reached that body weight prior to the end of the
experiment they were euthanized by CO2 gas to minimize extreme suffering. At the end of each
experiment, all remaining mice were euthanized by CO2 gas.
Table 3. Intestinal Scores for Experiments 1 and 3

Table 4. Intestinal Scores for Experiment 2

Intestinal
Score

Visible Stool
Consistency

Presence of
Blood as
determined by
hema-screen

Intestinal
Score

Visible Stool
Consistency

Presence of
Blood as
determined by
hema-screen

0

Normal

-

0

Normal

-

1

Normal

+

1

Normal

+

1

Soft

-

1

Soft

-

2

Soft

+

2

Soft

+

2

Loose

-

2

Loose

-

3
3

Loose
Diarrhea

+
-

3

Loose

+

4

Diarrhea

+

3
4
4
5

Diarrhea
Loose, bloody
Diarrhea
Diarrhea, bloody

+
+
+

2.2.

Counteraction of DSS-induced intestinal distress with Echinostomatid parasites
It has been previously shown that overexpression of the parasite protein galectin in

mice models of IBD protects the mice from developing intestinal distress by inducing a large TREG
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population (16). The effects of heat-killed echinostome metacercariae were tested in an
attempt to counteract the symptoms of DSS-induced intestinal distress (Fig. 4). As with the

Fig 4. Timeline of Experiment 3: Administration of heat-killed Echinostomatid metacercariae
to mice treated with 1% DSS. DSS was dissolved in drinking water for 6 days followed by
regular water for 3 days. Metacercariae or PBS was orally delivered to mice on Day 3.

previous tests, female C57BL/6 mice were used, but with eight mice per group to enable
detection of modest changes. Four groups were included to properly test all variables (DSS +
Parasites, Water + Parasites, DSS + PBS, and Water + PBS). Mice were identified and assigned
groups as described in section 2.1 (Table 5). 1% DSS treatment was given to mice in Groups 1
and 3 on days 0-5, and regular water on days 6-9. Regular water was given to mice in Groups 2
and 4 for all 9 days. Mice weight, stool consistency, and presence of fecal blood were recorded
daily. DSS solutions/water were changed every two days with the remaining volume used to
determine average water consumption. Food was also weighed every two days and used to
determine average food consumption in the same method as water consumption.
Echinostome metacercariae were isolated from infected Lymnaea snails that were
obtained through Dr. Sorensen (MSU, Mankato). The infected snails were dissected and
metacercariae were isolated and counted using a dissecting microscope and divided between 16
tubes (approximately 30-40 metacercaria per tube). Metacercariae were stored at room
temperature for 2-3 days in a salt solution (Lockes). On the day before administration to mice,
metacercariae were washed twice with PBS (phosphate-buffered saline). PBS was then added
to a total volume of 200 μL to all tubes placed in a thermocycler (Prime, TECHNE) at 72°C for 15
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Table 5. Mice ID numbers and initial weight for Experiment 3.
Treatment
Group

DSS + Parasite

Water +
Parasite

Age on
Day 0

Mice ID

Weight
(g)

7 w, 2 d
7 w, 2 d
7 w, 4 d
7 w, 4 d
7 w, 4 d
7 w, 5 d
7 w, 5 d
7 w, 5 d

232
225
243
245
248
252
254
256
Average=

16.7
17
16.65
14.4
15.8
16.68
18.16
18.97
16.795

7 w, 4 d
7 w, 3 d
7 w, 3 d
7 w, 3 d

233
226
236
237

15.92
17.58
17.75
16.5

7 w, 4 d

240

15.85

7 w, 4 d
7 w, 4 d
7 w, 4 d

244
246
247
Average=

17.62
16.95
17.05
16.9025

Treatment
Group

DSS + PBS

Water + PBS

Age on
Day 0

Mice ID

Weight
(g)

7 w, 1 d
7 w, 1 d
7 w, 4 d
7 w, 3 d
7 w, 3 d
7 w, 4 d
7 w, 4 d
7 w, 4 d

222
224
229
235
238
242
249
251
Average=

16.9
17.9
17.18
16.7
15.3
16.12
17.62
16.88
16.825

7 w, 2 d
7 w, 2 d
7 w, 3 d
7 w, 4 d

227
228
234
239

17.42
17.8
17.5
14.72

7 w, 4 d

250

17.93

7 w, 5 d
7 w, 5 d
7 w, 5 d

253
255
257
Average=

16.16
16.52
17
16.88125

minutes followed by 95°C for 15 minutes to kill the metacercariae, as previously demonstrated
in Hafalla et al. (27), and stored at 4°C overnight. Before weight and stool measurements were
collected on Day 3, metacercariae in PBS or 200 μL PBS was administered to mice using an 18gauge feeding tube 1.5 inches in length with a rounded tip. Mice were held by the scruff of the
neck and the gavage tube was placed in the diastema of the mouth and gently advanced along
the upper palate until the esophagus was reached. Once proper placement was verified,
metacercariae in PBS or PBS was administered by a 1 cc syringe attached to the end of the
feeding tube. After dosing, the mice were returned to their cage and monitored for signs of
labored breathing or distress for 5-10 minutes, and again after a few hours. Feeding tubes and
gavages were examined under the dissecting microscope to confirm that the metacercariae
were no longer present.
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After data collection on Day 9, all mice were euthanized by CO2 gas and dissected to
harvest the spleens and intestines. Spleens were placed into wells containing 1 mL sterile cold
PBS and disrupted with the flat plunger end of a sterile syringe. Cells suspensions were
transferred to sterile microfuge tubes containing 1 ml PBS and 100 μL of 1.1% IGEPAL (Alfa
Aesar) and kept on ice. Cell suspensions were vortexed for 1 minute, then centrifuged for 5
minutes at 8000 rpm. Supernatants were transferred to new sterile microfuge tubes and stored
at -20°C until analyzed for pro-inflammatory cytokines IFN-γ, parasite specific cytokine IL-4, and
regulatory cytokines IL-10 and IL-2 presence, using enzyme-linked immunosorbent assay (ELISA).
Intestines were placed into tubes containing 10 mL of 10% formalin and kept at 4°C for analysis
of colon length. To measure colon length, intestines were straightened and measured from the
ileocecal junction to the rectum.

2.3.

Analysis of splenic cytokines IL-4, IFN-γ, IL-2, and IL-10
Splenic supernatants were vortexed briefly and diluted twofold or tenfold with sterile

PBS. A Mouse TH1/TH2 Uncoated ELISA kit (ThermoFisher Scientific) was purchased. The
detection ranges given by the manufacturer for each cytokine were: IL-4, 4-500 pg/mL; IFN-γ,
15-2000 pg/mL; IL-2, 2-200 pg/mL; and IL-10, 30-4000 pg/mL. In all samples where the
calculated cytokine concentration was at or below the given sensitivity, it was graphed as the
lowest detectable level for that cytokine. To analyze cytokine concentrations, ELISA plates were
coated with 100 μL/well of IL-4, IFN-γ, IL-2, or IL-10 capture antibody in Coating Buffer then
sealed and incubated overnight. The following day wells were aspirated 3 times with Wash
Buffer and blocked with 200 μL/well of ELISA/ELISASPOT diluent. The plates were incubated at
room temperature for 1 hour, then the wells were aspirated once with Wash Buffer. Standards
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were prepared according to the manufacturer’s instructions and diluted to make a 6-point
standard curve (Fig. 5). 100 μL/well of standards or samples were added to appropriate wells.
Three or four specimens per treatment group were included with two or three replicates per
sample. The plates were sealed and incubated overnight. The following day, the wells were

Fig. 5. ELISA mouse TH1/TH2 standard curves used for cytokines IL-2, IL-4, IL-10, and IFN-γ.
Standards were diluted according to manufacturer’s instructions and used to make a 6-point curve
with two or three duplicates per sample. GraphPad Prism 7 was used to calculate standard curve
equations and R2 values. (A-B) TH1; TREG cytokine IL-2. (C) TH2; parasite specific cytokine IL-4. (D)
TH2; TREG cytokine IL-10. (E) TH1, pro-inflammatory cytokine IFN-γ.
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aspirated 5 times with Wash Buffer then 100 μL/well of IL-4, IFN-y, IL-2, or IL-10 diluted
detection antibody was added, and plates were sealed and incubated at room temperature for 1
hour. Wells were aspirated 5 times with Wash Buffer then 100 μL/well of diluted Avidin-HRP
enzyme was added, and plates were sealed and incubated at room temperate for 30 minutes.
Wells were aspirated 7 times with Wash Buffer then 100 μL/well of TMB (tetramethylbenzidine)
substrate solution was added, and plates were incubated at room temperature for 15 minutes.
50 μL/well of Stop Solution was added and plates were read at 450 nm in a MultiSkan Spectrum
plate reader (ThermoFisher). For IL-4, IFN-γ, and IL-10, one ELISA plate was analyzed (three or
four specimens per treatment group), and for IL-2, two ELISA plates were analyzed (five or six
specimens per treatment group). For all plates, GraphPad Prism 7 was used to calculate
standard curve equations and interpolate x-values. X-values were multiplied by 2 or 10
depending on the dilution factor to give cytokine concentrations.

2.4.

Statistical analysis
GraphPad Prism 7 software was used to perform all statistical testing. For comparison

of groups for weight change, intestinal score, food consumption, and water consumption,
repeated measures, 2-way ANOVA matching: stacked with Tukey’s multiple comparisons test
was performed. For data sets with missing values, mixed-affects model: matching: stacked with
Tukey’s multiple comparisons test was performed instead. For comparison of groups for colon
length, 1-way ANOVA with Tukey’s multiple comparisons test was performed. For comparison
of groups for IL-2 concentrations, 1-way ANOVA with Tukey’s multiple comparisons test, or
unpaired t test with Welch’s correction was performed. For all group comparisons, results were
expressed as group means with standard deviations. For cytokine concentrations, linear

20
regression was used to calculate standard curve equations and interpolate x values. For
comparison of individual data points, linear regression was used to calculate line equations, R2
values, and p values. P values of <0.05 were considered statistically significant for all tests.

3.

Results

3.1.

3%, 2.25%, and 1.5% DSS administered through drinking water induces acute intestinal

inflammation in C57BL/6 mice and causes excessive weight loss.
The overall goal of this study was to test the effects of non-living parasites on mice
models of IBD, by orally administering heat-killed metacercariae to mice treated with DSS.
Therefore, an optimal concentration of DSS which causes weight loss and loose stools while
allowing mice to survive the entire experiment (mice that lose >25% of their body weight must
be euthanized for ethical purposes), was necessary for this study.
An initial experiment was performed on 20 female, C57BL/6 mice, ages 6-8 weeks. Five
mice per treatment group were included. Individual mice were given ear tags prior to the
experiment and randomly assigned treatment groups. Individual mice were then weighed, and
treatments groups were adjusted slightly so that each group weighed approximately the same
(Table 1). DSS treatment cages were administered either 3%, 2.25%, or 1.5% DSS dissolved in
drinking water for 6 days, followed by regular water for 3 days. Control cages were
administered regular water for all 9 days. DSS solutions/water were replaced every two days
and the remaining volume from each cage was recorded. Average water consumption per
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mouse was calculated by dividing the remaining volume from each cage by the number of mice
(two or three) per cage. Weight, stool consistency, and presence of fecal blood (hema-screen)
were recorded daily for individual mice. Stool consistency and presence of fecal blood were
used to assign individual mice an intestinal score from 0-4 (Table 3). If a mouse lost >25% of its
body weight at any time during the experiment it was euthanized after data collection for that
day. At the end of 9 days, all remaining mice were euthanized.
Over the course of treatment, the group receiving 3% DSS began testing positive for
fecal blood on the first day and developed loose stools starting on the fourth day. When
compared to the control group, mice receiving 3% DSS had higher intestinal scores from the first
to the seventh day, (p<0.0001, 2- way ANOVA) (Fig. 6A). Mice receiving 3% DSS lost more
weight than the control group from the fifth to the seventh day (p≤0.0002, 2-way ANOVA) (Fig.
6B). Two mice receiving 3% DSS lost over 25% of their body weight on the seventh day, and the
remaining three mice on the eighth day (Table 6). Mice receiving 3% DSS also consumed less
water on the sixth day (p=0.055) and eighth day (p=0.0001, 2-way ANOVA) when compared to
the control group (Fig. 6C).
Similarly, the group receiving 2.25% DSS began testing positive for fecal blood on the
first day and developed loose stools starting on the fourth day. When compared to the control
group, mice receiving 2.25% DSS had higher intestinal scores from the first to the seventh day
(p<0.0001, 2-way ANOVA) (Fig. 6A). Mice receiving 2.25% DSS also lost more weight than the
control group from the fifth to the seventh day (p<0.001, 2-way ANOVA) (Fig. 6B). Four mice
receiving 2.25% DSS lost over 25% of their body weight on the eighth day, and the remaining
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Fig. 6. 3%, 2.25%, or 1.5% DSS induces acute intestinal distress in C57BL/6 mice but causes excessive weight
loss. 3%, 2.25%, or 1.5% DSS was dissolved in drinking water and administered to mice for 6 days, followed by
regular water for 3 days. Control mice were administered regular water for all 9 days. Five mice per
treatment group were included. For all panels, group means, and standard deviations are plotted. (A) Stool
consistency and presence of fecal blood (hema-screen) were used to provide mice an intestinal score of 0-4.
(B) Weight change during treatment, expressed as a percentage change from day 0. (C) Average water
consumption per mouse was calculated by dividing the remaining volume in cages every two days by the
number of mice per cage. Statistical differences of groups (p<0.05) was determined using RM 2-way ANOVA,
matching: stacked with Tukey’s multiple comparisons.

one mouse on the ninth day (Table 6). Mice receiving 2.25% DSS also consumed less water on
the eighth day when compared to the control group (p=0.0008, 2-way ANOVA) (Fig. 6C).
The group receiving 1.5% DSS began testing positive for fecal blood on the second day
and developed loose stools starting on the fifth day. When compared to the control group, mice
receiving 1.5% DSS had higher intestinal scores from the second to the seventh day (p<0.0005,
2-way ANOVA) (Fig. 6A). A linear equation was calculated for intestinal score from the fourth to
sixth day, when intestinal distress increased significantly (y=0.85x-1.383, linear regression)
(Appendix 1A). Mice receiving 1.5% DSS also lost more weight than the control group from the
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Table 6. Number of mice that lost over 25% of their initial
body weight on each day during Experiment 1.

fifth to the seventh day (p≤0.0012, 2-

Treatment
Group (n=5)

receiving 1.5% DSS lost over 25% of

# of mice that lost >25% body weight

way ANOVA) (Fig. 6B). One mouse

their body weight on the seventh day,
Days 1-6

Day 7

Day 8

Day 9

Control

0

0

0

0

1.5% DSS

0

1

2

2

2.25% DSS

0

0

4

1

3% DSS

0

2

3

N/A

an additional one mouse on the eighth
day, and the remaining two mice on
the ninth day (Table 6). Mice receiving

1.5% DSS also consumed less water on the eighth day when compared to the control group
(p=0.0005, 2-way ANOVA) (Fig. 6C).

3.2.

1% DSS administered through drinking water induces acute intestinal inflammation in

C57BL/6 mice without causing excessive weight loss or highly bloody stools.
Because the first tested range of 1.5%-3% DSS did not reveal an optimal model of IBD
(no differences between DSS groups were demonstrated for weight loss or intestinal scores, and
most mice in all DSS treatment groups lost >25% of their body weight before day 9), the
experiment was repeated using a lower range of 0.5%-1.5% DSS. Twenty female C57BL/6 mice,
ages 6-8 weeks were identified and assigned treatment groups using the same method as the
first experiment. Five mice per treatment group were included (Table 2). DSS treatment cages
were administered either 1.5%, 1%, or 0.5% DSS dissolved in drinking water for 6 days, followed
by regular water for 3 days. Control cages were administered regular water for all 9 days. DSS
solutions/water were replaced every two days and average water consumption per mouse was
calculated as previously described. Weight, stool consistency, and presence of fecal blood
(hema-screen) were recorded daily for individual mice. Mice were assigned an intestinal score
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from 0-5 as previously described, but with the addition of visible blood in stools as a factor
(Table 4). If a mouse lost >25% of its body weight at any time during the experiment, it was
euthanized after data collection for that day. At the end of 9 days, all remaining mice were
euthanized.
Similar to the first experiment, mice receiving 1.5% DSS began testing positive for fecal
blood on the second day and developed loose stools starting on the fifth day. Mice receiving
1.5% DSS had higher intestinal scores than control mice from the second to the eighth day
(p≤0.05), and higher scores than mice receiving 0.5% DSS from the fifth to the eighth day
(p<0.0037, mixed-affects model) (Fig. 7A). A linear equation was calculated for intestinal score
from the fourth to sixth day, when intestinal distress increases significantly (y=1.55x-4.483,
linear regression) (Appendix 1B). Mice receiving 1.5% DSS lost more weight than control mice
from the fifth to the eighth day (p≤0.0019), and lost more weight than mice receiving 0.5% from
the sixth to the eighth day (p<0.0001, 2-way ANOVA) (Fig. 7B).
Additionally, mice receiving 1.5% DSS had higher intestinal scores than mice receiving
1% DSS on the sixth day (p=0.0266, mixed model analysis), and lost more weight than mice
receiving 1% DSS on the seventh and eighth days (p≤0.0026, 2-way ANOVA). All five mice
receiving 1.5% DSS lost over 25% of their body weight on the eighth day (Table 7). Also, mice
receiving 1.5% DSS consumed less water than control mice and mice receiving 0.5% DSS on the
eighth day (p≤0.002, 2-way ANOVA) (Fig. 7C).
Similarly, the group receiving 1% DSS began testing positive for fecal blood on the
second day and developed loose stools starting on the fifth day. Mice receiving 1% DSS had
higher intestinal scores than control mice on the fourth to the the eighth day (p≤0.05) and
higher scores than mice receiving 0.5% DSS from the sixth to the eighth day (p≤0.0056, mixed-
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Fig. 7. 1% DSS induces acute intestinal distress in C57BL/6 mice without causing excessive weight loss or
highly bloody stools. 1.5%, 1%, or 0.5% DSS was dissolved in drinking water and administered to mice for 6
days, followed by regular water for 3 days. Control mice were administered regular water for all 9 days.
Five mice per treatment group were included. For all panels, group means, and standard deviations are
plotted. (A) Stool consistency and presence of fecal blood (hema-screen) were used to provide mice an
intestinal score of 0-5. (B) Weight change during treatment, expressed as a percentage change from day 0.
(C) Average water consumption per mouse was calculated by dividing the remaining volume in cages every
two days by the number of mice per cage. Statistical differences of groups (p<0.05) was determined using
RM 2-way ANOVA or mixed-affects model, matching: stacked with Tukey’s multiple comparisons.

model analysis) (Fig. 7A). A linear equation was calculated for intestinal score from the fourth to
sixth day (y=0.968x-2.128, linear regression) (Appendix 1C). Mice receiving 1% DSS lost more
weight than control mice and mice receiving 0.5% DSS from the sixth to the eighth day
(p<0.0001, 2-way ANOVA) (Fig. 7B).
One mouse receiving 1% DSS lost over 25% of their body weight on the eighth day, and
two additional mice on the ninth day (Table 7). Also, mice receiving 1% DSS consumed less
water than control mice and mice receiving 0.5% DSS on the eighth day (p≤0.0235, 2-way
ANOVA) (Fig. 7C).
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The group receiving 0.5% DSS
Table 7. Number of mice that lost over 25% of their initial
body weight on each day during Experiment 2.
Treatment
Group (n=5)

began testing positive for fecal blood
on the second day but did not

# of mice that lost >25% body weight

develop loose stools throughout the
Days 1-6

Day 7

Day 8

Day 9

Control

0

0

0

0

0.5% DSS

0

0

0

0

1% DSS

0

0

1

2

1.5% DSS

0

0

5

N/A

experiment. Mice receiving 0.5% DSS
did not had higher intestinal scores
or lose more weight than control

mice throughout the experiment. Mice receiving 0.5% DSS also did not consume less water than
control mice (Fig. 7C).

3.3.

Administration of heat-killed echinostome metacercariae to mice treated with 1% DSS

does not decrease induced intestinal distress but appears to exacerbate symptoms.
The results of the initial trial revealed that 1% DSS, when given for 6 days, induces acute
intestinal distress in C57BL/6 mice without causing excessive weight loss (four out of the five
mice did not lose 25% of their body weight before 9 days), or highly bloody stools; therefore, 1%
DSS was used in this phase of the project, which tested the effects of heat-killed echinostome
metacercariae on mice treated with DSS.
Thirty-two female, C57BL/6 mice, ages 6-8 weeks were identified and assigned
treatment groups in the same method as the first two experiments. Eight mice per treatment
group were included to ensure proper controls were tested: Group 1 (DSS + Parasite), Group 2
(Water + Parasite), Group 3 (DSS + PBS), and Group 4 (Water + PBS). (Table 5). Mice in Groups 1
and 3 were given 1% DSS dissolved in drinking water for 6 days, followed by regular water for 3
days. Mice in Groups 2 and 4 were given regular water for all 9 days. DSS solutions/water were
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replaced every two days and average water consumption per mouse was calculated as
previously described. Average food consumption per mouse was calculated in the same method
as water consumption.
Thirty to forty echinostome metacercariae, dissected from infected snails and heatkilled prior to the experiment, were orally administered on Day 3 to each mouse in Groups 1 and
2. PBS was orally administered on Day 3 to each mouse in Groups 3 and 4. Weight, stool
consistency, and presence of fecal blood (hema-screen) were recorded daily. Mice were
assigned an intestinal score from 0-4 as previously described in the first experiment (Table 3).
On the ninth day, all mice were euthanized, and spleens and intestines were dissected.
Intestines were stored in formalin for analysis of colon length. To measure colon length,
intestines were straightened and measured from the ileocecal junction to the rectum. Spleens
were disrupted and dissolved in a solution of 1 mL PBS with 0.1 mL 1.1% IPEGAL. Splenic
supernatants were kept at -20°C for analysis of pro-inflammatory cytokines IL-4 and IFN-γ, and
regulatory cytokines IL-2 and IL-10 by ELISA.
Group 1 (DSS + Parasite) began testing positive for fecal blood on the first day and
developed loose stools starting on the seventh day. Mice in Group 1 had higher intestinal scores
than mice in Group 2 (Water + Parasite) on the second day, and from the fourth to the ninth day
(p≤0.0379) and higher scores than Group 4 (Water + PBS) from the second to the ninth day
(p≤0.0049, 2-way ANOVA) (Fig. 8A). Mice in Group 1 (DSS + Parasite) also lost more weight than
mice in Group 2 (Water + Parasite) and Group 4 (Water + PBS) from the seventh to the ninth day
(p≤0.046, 2-way ANOVA) (Fig. 8B). Additionally, mice in Group 1 had higher intestinal scores and
lost more weight than mice in Group 3 (DSS + PBS) on the ninth day (p≤0.02, 2-way ANOVA).
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Fig. 8. The effects of heat-killed echinostome metacercariae on DSS-induced intestinal distress in C57BL/6 mice.
Two groups of experimental mice were given 1% DSS dissolved in drinking water for 6 days, followed by regular
water for 3 days. Two groups of control mice were given regular water for all 9 days. Eight mice per treatment
group were included. On Day 3, mice in Groups 1 and 2 were orally administered metacercariae and mice in
Groups 3 and 4 were orally administered PBS. For panels A, B, and D, group means, and standard deviations are
plotted. For panel C, each symbol represents one mouse. (A) Stool consistency and presence of fecal blood
(hema-screen) were used to provide an intestinal score of 0-4. (B) Weight change during treatment, expressed as
a percentage change from day 0. (C) Correlation of intestinal score to weight change on each day for all mice.
(D) Average food consumption per mouse was calculated by dividing the remaining volume in cages every two
days by the number of mice per cage. Statistical differences of groups (p<0.05) was determined using RM 2-way
ANOVA matching: stacked with Tukey’s multiple comparisons. Linear regression was used to determine R2 and p
values for panel C.

It was also revealed that mice in Group 1 (DSS + Parasite) did not consume less water
than mice in Group 2 (Water + Parasite) or Group 4 (Water + PBS) but did consume less food
than mice in Groups 2 and 4 on the eighth day (p<0.0001, 2-way ANOVA) (Fig. 8D). Colon length
analysis revealed that mice in Group 1 (DSS + Parasite) exhibited shorter colons after dissection
then mice in Groups 2 and 4 (p≤0.0037, 1-way ANOVA) (Fig 9B.).
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Fig. 9. Average water consumption and colon lengths of mice treated with 1% DSS for 6 days and
administered heat-killed metacercariae or PBS on Day 3. For panels A-B, group means, and standard
deviations are plotted. (A) Average water consumption per mouse was calculated by dividing the remaining
volume in cages every two days by the number of mice per cage (RM 2-way ANOVA, matching stacked with
Tukey’s multiple comparisons test). (B) Colon length was determined by straightening intestines and
measuring the length from the ileocecal junction to the rectum (1-way ANOVA with Tukey’s multiple
comparisons test). (C) Correlation of average water consumption on Day 8 to average weight change on Day
9 (linear regression). (D) Correlation of average water consumption on Day 8 to average colon length (linear
regression).

Mice in Group 3 (DSS + PBS) began testing positive for fecal blood on the first day and
developed loose stools starting on the seventh day. Mice in Group 3 (DSS + PBS) had higher
intestinal scores than mice in Group 4 (Water + PBS) from the fourth to the ninth day (p≤0.01),
and higher scores than mice in Group 2 (Water + Parasite) from the sixth to the ninth day
(p<0.0001, 2-way ANOVA) (Fig. 8A). A linear equation was calculated for intestinal score from
the fourth to sixth day (y=0.3750x-0.6042, linear regression) (Appendix 1D). Mice in Group 3
(DSS + PBS) lost more weight than mice in Groups 2 (Water + Parasite) and 4 (Water + PBS) on
the eighth and the ninth days (p≤0.0187, 2-way ANOVA) (Fig. 8B).
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It was also revealed that mice in Group 3 (DSS + PBS) did not consume less water than
mice in Groups 2 (Water + Parasite) and 4 (Water + PBS) (Fig. 9A) but did consume less food
than mice in Groups 2 and 4 on the eighth day (p<0.0001, 2-way ANOVA) (Fig. 8D). Colon length
analysis revealed that mice in Group 3 (DSS + PBS) exhibited shorter colons after dissection then
mice in Group 2 (Water + Parasite) and Group 4 (Water + PBS) (p≤0.0133, 1-way ANOVA) (Fig.
9B).
Mice in Group 2 (Water + Parasite) did not develop loose stools or progressive weight
loss throughout the experiment (Fig. 8A, B). However, two out of eight mice in Group 2 (Water
+ Parasite) tested positive for fecal blood on the third day, one mouse on the fourth day, one
mouse on the fifth day, and one mouse on the eighth day. Mice in Group 2 showed no
significant differences between mice in Group 4 (Water + PBS) for weight change, intestinal
scores, colon length, water consumption, or food consumption.
Mice in group 4 (Water + PBS) did not develop loose stools or progressive weight loss
throughout the experiment (Fig. 8A, B).
An overall correlation between weight change and intestinal score was observed for all
mice throughout the experiment (p<0.0001, linear regression) (Fig. 8C). This correlation was
further revealed for mice in DSS treatment groups (Appendix 2A, B), but not for mice in
untreated groups (Append. 2C, D). A correlation between average water consumption on the
eighth day and average weight change on the ninth day was observed (Fig. 9C), as well as a
correlation between average water consumption on the eighth day and average colon length
(Fig. 9D).
The results of the initial trial showed no differences between identical groups in the first
two experiments. Mice receiving 1.5% DSS in the first experiment showed no differences in
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weight change or water consumption throughout the experiment (Fig. 10A, B). Furthermore,
mice receiving water in the first experiment showed no difference in weight change or water
consumption than mice receiving water in the second experiment (Fig. 10A, B). However, our
results revealed that mice receiving 1% DSS and PBS in the third experiment lost less weight
than mice receiving 1% DSS in the second experiment from the sixth to the eighth day (p≤0.001,
2-way ANOVA) (Fig. 10C). The data also suggested that mice receiving water and PBS in the

Fig. 10. Analysis of weight change and water consumption between groups for all three experiments. For all
panels, group means, and standard deviations are plotted. (A) Weight change, expressed as a percentage
change from day 0, for mice receiving 1.5% DSS or water in the first two experiments. (B) Average water
consumption, measured by dividing the remaining volume every two days by the number of mice per cage,
for mice receiving 1.5% DSS or water in the first two experiments. (C) Weight change for mice receiving 1%
DSS or water in experiments two and three. (D) Average water consumption for mice receiving 1% DSS or
water in experiments two and three. Statistical differences between groups (p<0.05) was determined using
RM 2-way ANOVA matching: stacked with Tukey’s multiple comparisons.
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third experiment gained less weight than mice receiving water in the second experiment on the
eighth day (p=0.065, 2-way ANOVA) (Fig. 10C).
The results of the second experiment revealed that mice receiving 1% DSS consumed
less water on average than mice receiving water on the eighth day (p=0.0068, 2-way ANOVA)
(Fig. 10D), however mice receiving 1% DSS and PBS in the third experiment did not consume
significantly less water than mice receiving water and PBS in the third experiment (Fig. 10D).
Furthermore, while mice receiving water in the second experiment consumed approximately the
same amount of water on average throughout the experiment, mice receiving water and PBS in
the third experiment consumed less water on the sixth and eight days (Fig. 10D).

3.4.

Mice treated with 1% DSS and administered heat-killed echinostome metacercariae

showed decreased levels of regulatory cytokine IL-2 when compared to mice in all other groups.
Spleens from individual mice were dissected on Day 9 and were disrupted and dissolved
in a solution of 1 mL PBS and 0.1 mL 1.1% IPEGAL. Supernatants were analyzed using a Mouse
TH1/TH2 ELISA kit (Thermofisher Scientific). The detection ranges for each cytokine were
reported by the manufacturer to be: IL-4, 4-500 pg/mL; IFN-γ, 15-2000 pg/mL; IL-2, 2-200
pg/mL; and IL-10, 30-4000 pg/mL. In all samples where the calculated cytokine concentration
was at or below the given sensitivity, it was plotted as the lowest detectable concentration for
that cytokine (Table 8).
In order to detect levels of IL-2, a cytokine associated with TH1 cells and TREG cell
differentiation, five or six mice per treatment group were analyzed on two ELISA plates. We
showed that detectable levels of IL-2 (≥2 pg/ml) were present in the spleens of four out of five
tested mice in Group 1 (DSS + Parasite), all tested mice in Group 2 (Water + Parasite), all tested
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Table 8. Splenic levels of regulatory cytokines IL-2 and IL-10, parasite specific cytokine IL4, and pro-inflammatory cytokine IFN-γ in mice treated with 1% DSS for 6 days and
administered metacercariae or PBS on Day 3. Splenic supernatants from each treatment
group were analyzed by a mouse TH1/TH2 ELISA kit. Mice not tested were recorded as n/t.
Treatment Group

DSS + Parasite

Water + Parasite

DSS + PBS

Water + PBS

Mice ID
232
225
243
245
248
252
254
256
233
226
236
237
240
244
246
247
222
224
229
235
238
242
249
251
227
228
234
239
250
253
255
257

IL-2
n/t
5.547
*0
n/t
6.362
n/t
3.028
2.729
4.835
4.812
13.588
4.792
n/t
9.826
8.768
8.619
n/t
4.806
9.491
n/t
8.719
8.954
n/t
6.907
14.548
8.164
15.018
21.767
11.08
n/t
6.281
n/t

IL-4
n/t
n/t
n/t
n/t
*0
*0
*3.166
n/t
n/t
n/t
n/t
n/t
7.44
*0
9.566
*0
n/t
n/t
n/t
n/t
*0
*0
*3.176
n/t
n/t
n/t
n/t
n/t
*0
*0
*0
*0

IL-10
*0
*0
*0
431.695
n/t
n/t
n/t
n/t
*0
*0
*0
n/t
n/t
n/t
n/t
n/t
*0
*9.032
*0
*0
n/t
n/t
n/t
n/t
487.336
105.517
43.214
n/t
n/t
n/t
n/t
n/t

IFN-γ
*0
n/t
n/t
*0
*0
n/t
n/t
n/t
n/t
n/t
*0
n/t
n/t
*0
*0
*0
n/t
n/t
*0
n/t
*0
*0
n/t
*0
*0
n/t
n/t
34.921
*0
n/t
*0
n/t

* indicates concentration was below detectable level (IL-2=2 pg/ml, IL-4= 4 pg/ml, IL-10=
30 pg/ml, IFN-γ= 15 pg/ml)

mice in Group 3 (DSS + PBS), and all tested mice in Group 4 (Water + PBS) (Table 8, Fig. 11A).
Statistical analysis revealed that mice in Group 1 (DSS + Parasite) had significantly lower levels of
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IL-2 than mice in Group 4 (Water + PBS) (p=0.0036, 1-way ANOVA) (Fig. 11A).
Statistical analysis further revealed that mice in Group 1 (DSS + Parasite) had lower
levels of IL-2 than mice in Group 2 (Water + Parasite) (p=0.026) (Fig. 12C), and mice in Group 3
(DSS + Water) (p=0.0128, unpaired t test) (Fig. 12E).
A correlation between IL-2 concentration and weight change on the ninth day
(p=0.0345) (Fig. 12A), intestinal score on the ninth day (p=0.03) (Fig. 12B), and weight on the

Fig. 11. Analysis of splenic cytokines in mice treated with 1% DSS for 6 days and administered
metacercariae or PBS on Day 3. Spleens were harvested after 9 days and supernatants were
analyzed using ELISA. For all panels, group means, and standard deviations are indicated, and each
symbol represents one mouse. (A) TH1, TREG cytokine IL-2. (B) TH2 and parasite specific cytokine IL-4.
(C) TH2, TREG cytokine IL-10. (D) TH1 and pro-inflammatory cytokine IFN-γ. Statistical differences of
groups (p<0.05) was determined using 1-way ANOVA with Tukey’s multiple comparisons test.
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Fig. 12. Analysis of splenic cytokine IL-2 in mice treated with 1% DSS for 6 days and administered
metacercariae or PBS on Day 3. Spleens were harvested after 9 days and supernatants were analyzed for
regulatory cytokine IL-2 (n=5-6 per treatment group) using ELISA. For panels A and B, each symbol
represents one mouse. For panels C-F, group means, and standard deviations are plotted. (A) Correlation
of weight change on Day 9 and IL-2 concentration. (B) Correlation of intestinal score on Day 9 and IL-2
concentration. (C) IL-2 concentrations in groups receiving parasites. (D) IL-2 concentrations in groups
receiving PBS. (E) IL-2 concentrations in groups receiving DSS. (F) IL-2 concentrations in groups receiving
water. For panels A and B, linear regression was used to determine R2 and p values. Statistical differences
between groups (p<0.05) (Panels C-F) was determined using unpaired t test with Welch’s correction.

ninth day (p=0.0232, linear regression) (Appendix 3A) was observed. No correlation between IL2 concentration and initial weight was observed (Appendix 3B).
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In order to detect levels of IL-4, a cytokine associated with TH2 cells and parasite
expulsion, three or four mice per treatment group were analyzed on one ELISA plate. We
showed that detectable levels of IL-4 (≥4 pg/ml) were not present in the spleens of mice in
Group 1 (DSS + Parasite), Group 3 (DSS + PBS), or Group 4 (Water + PBS), and were present in
the spleens of two out of four tested mice in Group 2 (Water + Parasite) (Table 8, Fig. 11B).
In order to detect levels of IL-10, a cytokine associated with TH2, TREG, and BREG cells,
three or four mice per treatment group were analyzed on one ELISA plate. We showed that
detectable levels of IL-10 (≥30 pg/ml) were not present in the spleens of mice in Group 2 (Water
+ Parasite), or Group 3 (DSS + PBS), and were present in the spleen of one out of four tested
mice in Group 1 (DSS + Parasite), and all tested mice in Group 4 (Water + PBS) (Table 8, Fig. 11C).
In order to detect levels of IFN-γ, a cytokine associated with TH1 cells and autoimmunity,
three or four mice per treatment group were analyzed on one ELISA plate. We showed that
detectable levels of IFN-γ (≥15 pg/ml) were not present in the spleens of mice in Group 1 (DSS +
Parasite), Group 2 (Water + Parasite), or Group 3 (DSS + PBS), and were present in the spleen of
one out of four tested mice in Group 4 (Water + PBS) (Table 8, Fig. 11D).

4. Discussion

IBD is an autoimmune disease characterized by chronic intestinal inflammation and
epithelial damage (1,2,5-9). Epidemiological studies show an inverse relationship between the
frequency of helminth worm infections and IBD (1,2,5,7,8,15). IBD is common in industrialized
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countries where human helminth parasite infections are relatively sparse, whereas helminth
parasites, including species from Class Trematoda and Phylum Nematoda, are still common in
tropical countries where IBD is scarce. (1,2,5,8,15). Various studies have been conducted on
mice models of IBD in which mice were protected from chemically induced colitis (DSS or TNBS)
by a helminth infection, or an isolated helminth protein (galectin) delivered prior to inducing
symptoms of colitis (1,2,8,9,15,16,20). Parasite have been shown to release proteins that
induce a shift in TH1 to TH2 profiles, inhibiting IFN-γ and effector T cells, and producing IL-4 and
IL-10 (1-5,7-9,13,15,17-20). IFN-γ is a pro-inflammatory TH1 cytokine associated with the chronic
inflammation in autoimmune diseases such as IBD (1,6,9,15,16,20,22). IL-4 is a TH2 cytokine
associated with parasite expulsion in the initial phase of infection (1-3,5,7,15,17,18), and IL-10 is
a TH2 and regulatory cytokine often associated with the protective effects of helminth parasites
(1-3,5,7,11-13,15-18). Furthermore, parasite proteins may induce regulatory mechanisms
including the production of TREG cells, BREG cells, regulatory DCs and macrophages, and regulatory
cytokines TGF-β, IL-10, and IL-2 (1-5,7-9,13,15-21). IL-2 is a TH1 cytokine shown to induce TREG
cells following an infection (21).
We questioned whether noninfectious helminth parasites (heat-killed echinostome
metacercariae) delivered orally to C57BL/6 mice after several days of treatment with DSS would
decrease symptoms of DSS-induced colitis in mice. We hypothesized that mice treated with DSS
for 6 days and administered heat-killed metacercariae during DSS treatment would show less
weight loss, improved intestinal health, longer colons after dissection, decreased levels of proinflammatory cytokines IFN-γ or IL-4, and/or increased levels of regulatory cytokines IL-2 and IL10 when compared to mice treated with DSS and not administered metacercariae.
In order to test our hypothesis, we first established an optimal model of DSS-induced
colitis in female C57BL/6 mice by dissolving different concentrations of DSS (3%, 2.25%, 1.5%,
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1%, and 0.5%) in drinking water for 6 days, followed by regular water for 3 days. The goal of the
initial trial was to find an “mid-point” concentration of DSS that induces moderate intestinal
distress in female C57BL/6 mice living in the MSU, Mankato vivarium. Weight, stool consistency,
and presence of fecal blood were recorded daily, and water consumption was recorded every
two days. If mice lost over 25% of their body weight at any time they were euthanized after
data collection that day. After 9 days all remaining mice were euthanized following data
collection.
In the initial trial we demonstrated that mice given 3%, 2.25%, or 1.5% DSS for 6 days
developed highly bloody stools and/or excessive weight loss of >25% of their body weight. Also,
mice given 3%, 2.25%, 1.5%, and 1% DSS consumed less water on average than control mice.
One possible reason that mice consumed less water is that DSS may be bitter tasting, which
could condition mice to drink less. Another reason is that mice may eventually become too sick
to drink as much, leading to dehydration and an increase in symptoms. We further
demonstrated that mice given 1% DSS for 6 days developed loose stools that tested positive for
fecal blood, and lost more weight than control mice, but <25% of their body weight, and that
mice given 0.5% DSS developed soft stools which occasionally tested positive for fecal blood, but
did not lose more weight than control mice. From the results of the initial trial, we conclude
that 1% DSS is the optimal concentration that induces moderate intestinal distress; therefore 1%
DSS was chosen for the next phase of the study.
During the next phase, mice were fed heat-killed echinostome metacercariae in an
attempt to counteract symptoms of DSS-induced colitis. Two groups of experimental mice
received 1% DSS dissolved in drinking water for 6 days followed by regular water for 3 days, and
two groups of control mice received regular water for all 9 days. One group of experimental
mice and one group of control mice were orally administered heat-killed metacercariae in PBS
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on the third day of DSS treatment (DSS + Parasite, Water + Parasite). The other two groups
were orally administered PBS on the third day of DSS treatment (DSS + PBS, Water + PBS).
Weight, stool consistency, and presence of fecal blood were recorded daily, and water and food
consumption were recorded every two days. After 9 days all mice were euthanized, and
intestines and spleens were dissected. Colon lengths were recorded for individual mice and
spleens were disrupted and tested for inflammatory cytokine IFN-γ, parasite specific cytokine IL4, and regulatory cytokines IL-10 and IL-2, using ELISA.
In this phase we demonstrated that mice administered heat-killed echinostome
metacercariae during treatment with 1% DSS did not show a decrease in weight loss, improved
intestinal health, or longer colons after dissection than mice treated with 1% DSS but not
administered metacercariae. Inversely, on the ninth day of the experiment, mice administered
metacercariae during DSS treatment weighed significantly less and had poorer intestinal health
than mice treated with DSS but not administered metacercariae, suggesting that heat-killed
metacercariae may exacerbate symptoms of colitis in DSS treated mice. Analysis of splenic
cytokines showed that mice treated with DSS and administered metacercariae had lower levels
of regulatory cytokine IL-2 than mice treated with DSS but not administered metacercariae.
It was also noted that mice receiving 1% DSS in the second experiment lost more weight
than mice receiving 1% DSS in their drinking water and gavaged with PBS in the third
experiment, and that control mice receiving water in the second experiment gained more
weight than mice drinking water and gavaged with PBS in the third experiment. The data also
demonstrated that control mice receiving water in the second experiment drank more water
than mice drinking water and gavaged with PBS in the third experiment.
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Since there was little variation between the first and second experiments (mice
receiving 1.5% DSS or control mice in the first experiment did not show statistical differences
between weight change or water consumption compared to mice receiving 1.5% DSS or control
mice in the second experiment), this was a surprising result. It is possible that gavaging mice
affects the amount of water consumption and therefore weight change. If this experiment were
to be repeated, mice should also be gavaged during the initial trial when determining the
optimal level of DSS.
A significant correlation between weight change and intestinal score was observed in
mice treated with DSS, demonstrating that increased weight loss is associated with poorer
intestinal health. This was expected since DSS induces symptoms of both weight loss and
intestinal distress in mice (16,20,22,23). We also demonstrated that mice treated with DSS
exhibited shorter colons after dissection than mice that did not receive DSS, regardless of
parasite treatment. This result was expected since mice treated with DSS have been previously
shown to exhibit shorter colons (16,20). A correlation between average colon length and
average water consumption on Day 8 was observed, demonstrating that less water consumption
is associated with shorter colons. Since mice treated with DSS consume less water it is possible
that dehydration is what causes the shortening of colons. A correlation between weight change
on Day 9 and average water consumption on Day 8 was also observed, demonstrating that less
water consumption contributes to more weight loss.
Previous literature describing the effects of parasites on mice models of colitis described
a shift in T cell subsets leading to a decrease in inflammatory cytokines and an increase in
regulatory cytokines (16). In this study we demonstrated that mice administered metacercariae
during DSS treatment showed lower levels of the regulatory cytokine IL-2 than mice in all other
groups. A correlation between IL-2 concentrations and weight change, intestinal score, and
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weight on the ninth day was observed, demonstrating that lower IL-2 levels are associated with
increased symptoms of colitis. We did not observe a correlation between IL-2 concentration
and initial weight, confirming that IL-2 levels analyzed in this study are not dependent on mouse
weight, but rather on intestinal health.
Since previous literature describing the effects of parasites on DSS-induced colitis in
mice did not analyze IL-2, we questioned the role of IL-2 in mice treated with DSS and
administered heat-killed metacercariae. We confirmed that a decrease in IL-2 levels was driven
by both DSS treatment and parasite administration. The DSS model induces a shift in T cell
subsets, leading to an increase in TH1 cells and pro-inflammatory cytokines. Because of this we
would expect to see lower levels of regulatory cytokines during symptoms of colitis. IL-2 is
thought to induce TREG cells at the end of an infection. The data showed that mice treated with
DSS but not administered parasites exhibited intestinal distress while treated with DSS but
showed a decrease in symptoms once regular water was given, suggesting that IL-2 was
produced once DSS was no longer administered, leading to remission in mice.
Mice treated with DSS and administered parasites continued to exhibit intestinal
distress once regular water was given. The data also showed that mice not treated with DSS but
administered parasites exhibited acute intestinal distress on the third day, several hours after
metacercariae were orally administered. Cytokine analysis revealed that mice receiving parasite
treatment but not DSS showed detectable levels of IL-4 (although it is noted that only a small
sample size was tested for this cytokine.) In the initial stage of a parasite infection, a proinflammatory response and the production of cytokine IL-4 is induced, which allows the body to
expel the parasites, while the long-term phase of a parasite infection induces a regulatory
response. It is possible that a single dose of heat-killed metacercariae fed to mice initiates or
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prolongs a pro-inflammatory immune response and may block the production of regulatory
cytokine IL-2 in DSS-treated mice once DSS is no longer administered.
Detectable levels of the regulatory cytokine IL-10 were present in the spleens of all
tested mice not treated with DSS or administered parasites, and in one tested mouse treated
with DSS and administered parasites. Detectable levels of the pro-inflammatory cytokine IFN-γ
were only present in tested mice not treated with DSS or administered parasites. It is noted that
only a small sample size was tested for both IL-10 and IFN-γ. Because of faulty reagents or
equipment, only one ELISA plate was conclusive for each cytokine. Because of this, three or four
mice per treatment group were analyzed for IFN-γ, IL-4, and IL-10. If this experiment were to be
repeated it may be necessary to measure fewer cytokines in order to have more replicates.
In this study we also demonstrated that mice treated with 1% DSS consumed less food
on average then mice not treated with DSS, suggesting that as mice become sick, they are
unable to eat as much. Because food consumption was not measured during the initial trial, it
is possible that a lack of nutrients, as well as dehydration, contributes to weight loss in mice
models of colitis.
Previous literature describing the effects of parasites in mice models of colitis reported
inducing a parasite stimulus before treatment with DSS and demonstrated a protective response
of parasites against DSS-induced colitis (1-3,5,7-9,15,16,20). Also, previous literature reported
inducing a long-term parasite stimulus, via a live infection, or multiple injections with galectin. It
is unknown if non-living, whole parasites can be used as a form of treatment in mice models of
colitis. Because the parasites in this study were noninfectious and delivered while symptoms of
colitis were present, they most likely passed through the digestive tract. During the clinical
phase of colitis, nutrients and water are less likely to be absorbed through the intestinal tract. It

43
is possible that heat-killed metacercariae delivered during DSS treatment do not remain inside
of the body long enough to induce a regulatory immune response and decrease symptoms of
colitis.
If this experiment were to be continued, multiple doses of metacercariae may be
needed to stimulate the immune system into forming a regulatory response. This could be done
by obtaining more infected snails and feeding metacercariae to mice on multiple days. Also, the
metacercariae may need to be administered during a period of remission, so that they remain
inside of the body long enough to induce a regulatory immune response. This is could be done
by expanding the experiment to 18 days and administering metacercariae in between treatment
with DSS.
Based on the data we conclude that heat-killed metacercariae administered to female
C57BL/6 mice during treatment with 1% DSS do not protect mice from DSS-induced symptoms
of colitis but appear to exacerbate symptoms, possibly by blocking regulatory IL-2 production
once DSS administration is stopped. Furthermore, a single dose of metacercariae may not be
sufficient to alter the immune symptom to favor a regulatory response, and multiple doses
given throughout DSS treatment or during periods of remission may be required. Further
studies are necessary to determine whether delivering non-infectious whole parasites as a
treatment method can stimulate the immune system to form a regulatory response, thus
reducing chronic inflammation and relieving symptoms of autoimmunity.
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Appendix 1. Linear equations of intestinal distress for mice treated with 1.5% DSS or 1% DSS for all
experiments. Intestinal scores increase at a significant rate from the fourth to sixth day when mice
are treated with 1% DSS or 1.5% DSS for 6 days. For panels A-C, five mice were included, and for
panel D, eight mice were included. (A) Mice receiving 1.5% DSS during experiment 1. (B) Mice
receiving 1.5% DSS during experiment 2. (C) Mice receiving 1% DSS during experiment 2. (D) Mice
receiving 1% DSS during experiment 3. Linear regression was used to determine line equations and
R2 values.
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Appendix 2. Correlation of weight change and intestinal score for mice treated with 1% DSS for 6
days and administered metacercariae or PBS on day 3. For all panels, correlation of weight change,
expressed as a percentage change from day 0, to intestinal score (0-4) are graphed for individual
mice (n=8 per group). (A) DSS and parasite treatment. (B) DSS treatment and PBS. (C) Water and
parasite treatment. (D) Water and PBS. Linear regression was used to determine R2 and p values.
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Appendix 3. Correlations of splenic cytokines and weight, weight change, or intestinal score on Day 9
in mice treated with 1% DSS and administered metacercariae or PBS on Day 3. Spleens were
harvested after 9 days and supernatants were tested for regulatory cytokines IL-2 and IL-10, parasite
specific cytokine IL-4, and pro-inflammatory cytokine IFN-γ using ELISA. For all panels, each symbol
represents one mouse. (A) Weight on Day 9 and IL-2 concentration. (B) Weight on Day 0 and IL-2
concentration. (C) Weight change on Day 9, expressed as a percentage change from Day 0, and IL-4
concentration. (D) Intestinal score on Day 9 and IL-4 concentration. Linear regression was used to
determine R2 and p values.
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Appendix 3 (continued). Correlations of splenic cytokines and weight change or intestinal score on
Day 9 in mice treated with 1% DSS and administered metacercariae or PBS on Day 3. For all panels,
each symbol represents one mouse. (E) Weight change on Day 9 and IL-10 concentration. (F)
Intestinal score on Day 9 and IL-10 concentration. (G) Weight change on Day 9 and IFN-γ
concentration. (H) Intestinal score on Day 9 and IFN-γ concentration. Linear regression was used to
determine R2 and p values.

50

Appendix 4. Weight change and intestinal scores for individual mice treated with 1% DSS for 6
days and administered heat-killed metacercariae or PBS on Day 3. For left panels, weight change,
expressed as a percentage change from day 0, are graphed for individual mice (n=8 per group).
For right panels, intestinal scores (0-4) are graphed for individual mice (n=8 per group). Panels AB: DSS and parasite treatment. Panels C-D: DSS treatment and PBS.
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Appendix 4 (continued). Weight change and intestinal scores for individual mice treated with
1% DSS for 6 days and administered heat-killed metacercariae or PBS on Day 3. For left panels,
weight change, expressed as a percentage change from day 0, are graphed for individual mice
(n=8 per group). For right panels, intestinal scores (0-4) are graphed for individual mice (n=8 per
group). Panels E-F: Water and parasite treatment. Panels G-H: Water and PBS.

